MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'hospira'. Sat, 03 Sep 2011 02:51:35 +0100 http://www.medworm.com/index.php?rid=5118643&cid=t_161637_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fdrug-manufacturer-issues-statement-banning-drug-used-for-lethal-injections%2F2011.08.11 A friend sent me a press release a few days ago and I still find myself thinking about it. Here in the United States capital punishment is still legal in many states and is performed, frequently, by lethal injection. Prisoners sentenced to death have an IV placed in their arm which is then infused with the following three solutions: A barbiturate like Sodium Pentothal or Nembutal, used to induce anesthesia A paralytic like pancuronium bromide or succinylcholine chloride, used to stop respiration Potassium chloride used to stop electrical conduction in the heart I remember a few years ago drug manufacturer Hospira, the producer of Sodium Pentothal, issued a statement that it disapproved of its drug being used in capital punishment.  But, that was as far as their opposition went and, alth... Better Health blogs http://www.medworm.com/rss/comments.php?id=5118643 Thu, 11 Aug 2011 14:00:36 +0100 5118643 http://www.medworm.com/index.php?rid=4911820&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FWRej8NgksWI%2F Good morning, everyone, and how are you today? A scorcher is predicted to envelope the Pharmalot corporate campus. We plan to keep cool by perusing interesting documents and chatting up interesting people. We will also break later to appear on a PhRMA panel on social media. To prepare, we are downing a few cups of stimulation - our flavor today is Southern Pecan. Meanwhile, here are some nifty tidbits from around your world. Watch out for the heat and see you soon… Pfizer Teams With Harvard In $100M Drug Discovery Deal (Bloomberg News) Merck Ends Trial Of Intercell Vaccine For MRSA (Reuters) Covidien Seeks A Buyer For Its Pharma Unit (Bloomberg News) Orphan Drug Development Success Remains Elusive (Gen New) US Seeks Prison Sentences For Device Execs (Associated Press) Glaxo Faces Adv... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4911820 Wed, 08 Jun 2011 12:00:08 +0100 4911820 http://www.medworm.com/index.php?rid=4636658&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FA99JMnl2Rrw%2F For the second time this month, the US International Trade Commission has agreed to investigate a complaint hinging on a patent dispute involving different drugmakers. This time around, Femira Pharma accuses Merck and numerous retailers, including CVS Caremark Wal-Mart, of infringing on a patent because the drugmaker and pharmacies import or sell Merck’s NuvaRing vaginal ring birth control device (see the ITC notice). In its complaint, Femira argues its patent generally relates to a medicated intravaginal device, such as a vaginal ring, for transvaginal delivery of a medication to a woman’s uterus. Femira also maintins the drug delivery system described in its patent allows delivery in lower concentrations than those needed for systemic treatment and so offers a lower systemic ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4636658 Fri, 25 Mar 2011 14:46:48 +0100 4636658 http://www.medworm.com/index.php?rid=4615429&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F4eYAhPyUqZA%2F In an unusual move to thwart generic competition, Eli Lilly has succeeded in convincing the US International Trade Commission to investigate its complaint that Hospira and three suppliers are using a manufacturing process that infringes a patent on its Gemzar cancer med. And Lilly hopes the ITC will block importation of Hospira’s generic version, which is known as gemcitabine (see ITC notice here). In its complaint, Lilly charges that the patented method for making Gemzar, which is used to treat breast, lung, ovarian and pancreatic cancer, is “the most commercially viable process available for manufacturing gemcitabine” and “involves less steps, higher yields and lower costs,” according to the Lilly complaint. Hospira and its suppliers are charged with illegal... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4615429 Mon, 21 Mar 2011 11:58:20 +0100 4615429 http://www.medworm.com/index.php?rid=4592694&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fw63z2G8UvTM%2F After spending more than a decade growing into a behemoth by single-mindedly pursuing big acquisitions - think Warner-Lambert, Pharmacia and Wyeth - Pfizer is now signaling a change of heart. To wit, the drugmaker is said to considering the spin off or sale of all four non-pharma units, including nutritionals, consumer health, animal health and a business that makes capsules. Moreover, Pfizer may even shed what it calls the Established Products division, a $10 billion operation that includes off-patent meds, the Greenstone generics unit and biosimilars, according to an investor note from Sanford Bernstein analyst Tim Anderson. He writes that such moves would trim Pfizer nearly in half - from about $67 billion in annual revenue to between $35 billion and $40 billion. “If we hadn&#8217... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4592694 Mon, 14 Mar 2011 14:39:05 +0100 4592694 http://www.medworm.com/index.php?rid=4575246&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FDiD_H2Gzp3I%2F Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that MCS Healthcare Public Relations promoted Brian Thompson to senior vp, which means he will also join the agency’s executive committee. For the past five years, he has worked with several drugmakers to promote meds in various therapeutic areas,... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4575246 Fri, 11 Mar 2011 12:39:14 +0100 4575246 http://www.medworm.com/index.php?rid=4570763&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FNmT5C8tDVOY%2F Hello, everyone, and nice to see you again. A spot of rain is falling on the Pharmalot corporate campus, but our spirits remain sunny thanks to the Morning Mayor, who would always say: ‘Every brand new day should be unwrapped like a precious gift.’ So while you tug on the ribbon, please join us for a cup of stimulation and help us scan the news of the world. Hope your day goes well and do stay in touch… FDA Approves First New Lupus Drug In 56 Years (Associated Press) Vertex Moves Ahead With Epilepsy Drug (Boston Business Journal) J&J Hip Replacement Has 49 Percent UK Failure Rate (Bloomberg News) Epizyme And Eisai Form A Partnership (Boston Globe) FDA OKs Hospira Generic Of Taxotere Cancer Med (Reuters) Quintiles Eyes More Deals With Credit Facility (Outsourcing Phar... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4570763 Thu, 10 Mar 2011 12:59:47 +0100 4570763 http://www.medworm.com/index.php?rid=4436939&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FsCHNSKX3aBI%2F The ongoing shortage of a drug used for prison executions has now ensnared the FDA. Six inmates on death row in prisons in Arizona, California and Tennesse yesterday filed a lawsuit claiming the agency violated federal law by allowing the states to import thiopental sodium, even though there was no official review for safety and effectiveness. In other words, there are no approved suppliers. The shortage began when Hospira stopped making thiopental in 2009, prompting prisons to seek alternates. Last month, the FDA decided to permit imports, but declined to vouch for the meds, even though one recent execution may have involved an expired import (back story). “Reviewing substances imported or used for the purpose of state-authorized lethal injection clearly falls outside of FDA’s exp... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4436939 Fri, 04 Feb 2011 23:53:10 +0100 4436939 http://www.medworm.com/index.php?rid=4429224&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F1F3Beuifq9s%2F Certainly, at hospitals. In fact, the shortage of injectable generics for cancer and other serious diseases is forcing many hospitals to scramble to locate meds or find alternatives. In some cases, the FDA has allowed imports, but the agency approval process has also meant fewer new available generics. “We think this is near a crisis situation,” Bona Benjamin, a director at the American Society of Health-System Pharmacists, a pharmacist trade group, tells The Wall Street Journal. Numbers, of course, help tell the story. The FDA reports a record 178 drug shortages in 2010, up from 157 the year earlier and 55 five years ago. And here is the latest list. You’ll notice this is much shorter than the list indicating shortages that have been resolved (take a peek). The problem,... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4429224 Wed, 02 Feb 2011 18:03:31 +0100 4429224 http://www.medworm.com/index.php?rid=4419453&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FXql_GCjRfw8%2F Welcome to the working week. We hope your weekend was refreshing and relaxing. Now, of course, the time has come to resume the routine of meetings and deadlines. To cope, we are, once again, armed with a cup of stimulation - our flavor today is chocolate raspberry truffle - and invite you to join us. Meanwhile, here are some interesting tidbits to begin the day. Hope your day goes well and do stay in touch. We enjoy hearing what goes on in your world… FDA OKs Novartis Meningitis Vaccine In Children, No Infants (Bloomberg News) Radiologist Wins $482M In Stent Patent Suit Against J&J (Star-Ledger of NJ) Pfizer Order To Pay $142M Over Neurontin Marketing Is Upheld (MarketWatch) Glaxo Settles Avandia Suit On Eve Of Trial (Bloomberg News) Dr. Reddy’s Gets Court Approval To Sell... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4419453 Mon, 31 Jan 2011 12:51:11 +0100 4419453 http://www.medworm.com/index.php?rid=4389159&cid=t_161637_83_f&fid=34856&url=http%3A%2F%2Finsidesurgery.com%2F2011%2F01%2Fhospira-stop-making-death-penalty-drug-sodium-thiopental%2F Drug manufacturer Hospira has decided not to produce sodium thiopental at its new manufacturing facility in Milan, Italy under pressure from Italian authorities. The drug is part of a cocktail given to many patients who receive the death penalty by lethal injection and had until recently been manufactured at Hospira’s Virginia facilities. (Source: Inside Surgery) Inside Surgery blogs http://www.medworm.com/rss/comments.php?id=4389159 Sun, 23 Jan 2011 05:15:28 +0100 4389159 http://www.medworm.com/index.php?rid=4225658&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FHWWmPeS2DuY%2F Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Receptos hired Faheem Hasnain as ceo and president. Most recently, he was ceo and president at Facet Biotech, which was recently bought by Abbott Laboratories. Previously, he held various executive positions at PDL BioPharma, Biogen Idec, Brist... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4225658 Fri, 03 Dec 2010 12:50:31 +0100 4225658 http://www.medworm.com/index.php?rid=4077592&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FyEG2mI_la8Y%2F For those who like to keep track of the revolving door between industry and regulators, it is worth noting that Gary Buehler, who for many years ran the FDA’s Office of Generic Drugs, is joining Teva Pharmaceuticals as vp for regulatory strategic operations. Teva, of course, is the world’s biggest supplier of generics. The move comes just a few months after Buehler was reassigned to run the FDA’s Office of Pharmaceutical Science after FDA commish Margaret Hamburg complained publicly about a backlog of generic drug approvals (back story). The backlog went from 891 in fiscal year 2005 to 1,912 in fiscal year 2010, although Buehler was known inside the FDA to battle for funding for reviewers. To cope, the agency continues to explore the notion of imposing user fees on generi... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4077592 Mon, 18 Oct 2010 12:54:18 +0100 4077592 http://www.medworm.com/index.php?rid=4045394&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FHTtxY7fTDCU%2F Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is something that’s become a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Scrip Intelligence hired Christopher Bowe as US healthcare analyst. Before joining the information service, he worked in strategic affairs at Schering-Plough, and was previously US healthcare correspondent and Chicago co... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4045394 Fri, 08 Oct 2010 12:12:56 +0100 4045394 http://www.medworm.com/index.php?rid=3737297&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FYZBcU_qPc9w%2F Good morning, everyone. We hope you are holding up during the heatwave. Our theory is that drinking something hot actually helps cool us off. So you will not be surprised to learn that we are brewing yet another cup of stimulation to get us going. While we are occupied, please enjoy some of the latest tidbits. Have a great day and stay in touch… Lilly May Add 100 Jobs At Irish Facility (RTE News) Genzyme Signs Hospira For Packaging Deal (Reuters) Novartis Challenges USPTO Patent Extension Policy (Law360/Forbes) Tylenol Sales Are Down 65 Percent (Ad Age) Pfizer Expands Nutrition Plant (Frontier India) Alnara’s Strategy Toward Its Deal With Lilly (Xconomy) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3737297 Thu, 08 Jul 2010 12:14:07 +0100 3737297 http://www.medworm.com/index.php?rid=3511779&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FN-JZjFwiXwY%2F The agency sent a letter to the Israeli drugmaker, because its Parenteral Medicines unit failed to correct several manufacturing issues at its Irvine, California, facility, which resulted in contaminated batches of an injectable anesthetic called Propofol, which is widely used in operating rooms and intensive care units. Propofol was last in the news in a big way when it was discovered that Michael Jackson (you know, the former king of pop) died of an overdose of the med (see here). Teva recalled thousands of vials last year after elevated levels of toxins were discovered. At the time, the FDA said more than 40 patients suffered fever after operations, chills and flu-like symptoms. The December 2009 letter, which was posted today on the FDA site, noted that Teva responded six times to the ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3511779 Tue, 27 Apr 2010 21:16:51 +0100 3511779 http://www.medworm.com/index.php?rid=3142835&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FHYV25kXFeLE%2F Top of the morning to you. Hope your adjustment to the usual work routine went well yesterday. As always, there is much to do. First up on our agenda - shepharding one of the short people to the local schoolhouse. So while we prepare for the challenge, here are a few items to help you with your own challenges. Here’s to a good day… Schering-Plough Settles Clarinex Investor Suit For $165M (Bloomberg News) Pharmacy Goes To Trial For Distributing Steroids (FoxTV10.com) Biogen CEO To Retire In June; Is Icahn Happy? (TheStreet.com) Alcon Directors Criticize Novartis Takeover Tactic (Reuters) Genzyme Taps Hospira For Manufacturing Help (PharmaTimes) TCG Life Signs Deal With Pfizer (The Economic Times) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3142835 Tue, 05 Jan 2010 11:49:43 +0100 3142835 http://www.medworm.com/index.php?rid=1414900&cid=t_161637_113_f&fid=34695&url=http%3A%2F%2Fmedicalconnectivity.com%2F2008%2F05%2F01%2Fhospira-acquires-sculptor%2F Today Hospira announced they have acquired Sculptor Developmental Technologies (press release). A subsidiary of St. Clair Health Corporation, Sculptor was a software engineering company formed by St. Clair Hospital in 1993 to create solutions that St. Clair couldn’t buy from vendors. Sculptor’s solutions include a barcode meds administration system, an enterprise report print management application, advanced printing for Eclipsys, fax distribution software and similar tools. Sculptor has an installed base of more than 125 hospitals in North America. The deal includes St. Clair Hospital serving as a development and test site for Hospira medication management products. Obligatory chest thumping: “This acquisition brings together two leaders in healthcare IT — Hospira ... Medical Connectivity Consulting blogs http://www.medworm.com/rss/comments.php?id=1414900 Fri, 02 May 2008 03:33:08 +0100 1414900 http://www.medworm.com/index.php?rid=1119360&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F207045342%2F Lying on the beach? Sprawled across the couch? Maybe you’re in the office trying to catch up while things are quiet? Wherever you are, there are always interesting tales to read. Here are some we found during our own time off this week (Did we say we were on vacation?) Enjoy…. A little company in Canada is high on marijuana. Cannasat Therapeutics is testing its first product, CAT-310, which it says takes away the so-called “buzz” of marijuana that makes some terminally and chronically ill patients, particularly the elderly, uncomfortable and anxious, The Toronto Star reports. The med is aimed directly at the $4 billion neuropathic pain market that is mainly serviced by various opiates, anti-convulsants and anti-depressants. The idea is to mimic smoked cannabis throu... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1119360 Thu, 27 Dec 2007 14:45:04 +0100 1119360 http://www.medworm.com/index.php?rid=1107127&cid=t_161637_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F203387034%2F Rise and shine. We can tell the pace is slowing down for many people, but we remain busy. And so here are a few items to keep you occupied as you sort through the morning… EC Approves Hospira’s Version Of J&J’s Procrit (PharmaTimes) Lilly’s Taurel Takes A Cut Without CEO Pay (Bloomberg News) Canadian Rx Growth Slows, But Generics Soar (PharmaTimes) Par Pharma’s Quarterly Revenue Rises (MarketWatch) FDA Issues Non-Approvable Letter To Indevus For Bladder Drug (Forbes/AP) Share / E-mail (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1107127 Thu, 20 Dec 2007 12:46:00 +0100 1107127